Andorra vs Middle East, North Africa, Afghanistan & Pakistan: Immunization, HepB3
Immunization, HepB3 over time
- Andorra
- Middle East, North Africa, Afghanistan & Pakistan
How they compare
Andorra currently reports 97.0% against 84.4% in Middle East, North Africa, Afghanistan & Pakistan, a difference of 12.6%.
That makes Andorra's figure about 1.1 times Middle East, North Africa, Afghanistan & Pakistan's.
Across all 28 years both countries report, Andorra has been ahead every year.
Andorra ranks 26th and Middle East, North Africa, Afghanistan & Pakistan ranks 24th of 188 countries.
Andorra has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Andorra | Middle East, North Africa, Afghanistan & Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 76.7% | 34.5% | 42.2% | Andorra |
| 2000s | 85.7% | 63.5% | 22.2% | Andorra |
| 2010s | 96.3% | 80.5% | 15.8% | Andorra |
| 2020s | 97.2% | 83.4% | 13.8% | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Andorra or Middle East, North Africa, Afghanistan & Pakistan?
- Andorra, at 97.0% against 84.4% in Middle East, North Africa, Afghanistan & Pakistan as of 2024.
- What is the difference in immunization, hepb3 between Andorra and Middle East, North Africa, Afghanistan & Pakistan?
- 12.6%, with Andorra ahead.
- How many years of comparable data are there for Andorra and Middle East, North Africa, Afghanistan & Pakistan?
- 28 years are reported by both, from 1997 to 2024.
- How do Andorra and Middle East, North Africa, Afghanistan & Pakistan rank globally for immunization, hepb3?
- Andorra ranks 26th and Middle East, North Africa, Afghanistan & Pakistan ranks 24th of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.